PATHOGENETIC TREATMENT OF ARTERIAL HYPERTENSION: THE PLACE OF CALCIUM ANTAGONISTS
The paper describes the key aspects of arterial hypertension pathogenesis and the relevant therapeutic strategies. The authors discuss the role of increased peripheral vascular resistance and hypervolemia as factors which can be targeted by calcium channel blockers. The new evidence on this medicati...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2013-04-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/182 |
id |
doaj-5e860079eb0f485b8f129768b6c2ff39 |
---|---|
record_format |
Article |
spelling |
doaj-5e860079eb0f485b8f129768b6c2ff392021-07-28T13:50:56Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252013-04-01122858810.15829/1728-8800-2013-2-85-88182PATHOGENETIC TREATMENT OF ARTERIAL HYPERTENSION: THE PLACE OF CALCIUM ANTAGONISTSE. O. Taratukhin0N. N. Teplova1N. I. Pirogov National Medical Research UniversityN. I. Pirogov National Medical Research UniversityThe paper describes the key aspects of arterial hypertension pathogenesis and the relevant therapeutic strategies. The authors discuss the role of increased peripheral vascular resistance and hypervolemia as factors which can be targeted by calcium channel blockers. The new evidence on this medication class, including the third-generation calcium antagonists, is presented.https://cardiovascular.elpub.ru/jour/article/view/182vasospasmhypervolemiahypernatremiacardiac output |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
E. O. Taratukhin N. N. Teplova |
spellingShingle |
E. O. Taratukhin N. N. Teplova PATHOGENETIC TREATMENT OF ARTERIAL HYPERTENSION: THE PLACE OF CALCIUM ANTAGONISTS Кардиоваскулярная терапия и профилактика vasospasm hypervolemia hypernatremia cardiac output |
author_facet |
E. O. Taratukhin N. N. Teplova |
author_sort |
E. O. Taratukhin |
title |
PATHOGENETIC TREATMENT OF ARTERIAL HYPERTENSION: THE PLACE OF CALCIUM ANTAGONISTS |
title_short |
PATHOGENETIC TREATMENT OF ARTERIAL HYPERTENSION: THE PLACE OF CALCIUM ANTAGONISTS |
title_full |
PATHOGENETIC TREATMENT OF ARTERIAL HYPERTENSION: THE PLACE OF CALCIUM ANTAGONISTS |
title_fullStr |
PATHOGENETIC TREATMENT OF ARTERIAL HYPERTENSION: THE PLACE OF CALCIUM ANTAGONISTS |
title_full_unstemmed |
PATHOGENETIC TREATMENT OF ARTERIAL HYPERTENSION: THE PLACE OF CALCIUM ANTAGONISTS |
title_sort |
pathogenetic treatment of arterial hypertension: the place of calcium antagonists |
publisher |
«SILICEA-POLIGRAF» LLC |
series |
Кардиоваскулярная терапия и профилактика |
issn |
1728-8800 2619-0125 |
publishDate |
2013-04-01 |
description |
The paper describes the key aspects of arterial hypertension pathogenesis and the relevant therapeutic strategies. The authors discuss the role of increased peripheral vascular resistance and hypervolemia as factors which can be targeted by calcium channel blockers. The new evidence on this medication class, including the third-generation calcium antagonists, is presented. |
topic |
vasospasm hypervolemia hypernatremia cardiac output |
url |
https://cardiovascular.elpub.ru/jour/article/view/182 |
work_keys_str_mv |
AT eotaratukhin pathogenetictreatmentofarterialhypertensiontheplaceofcalciumantagonists AT nnteplova pathogenetictreatmentofarterialhypertensiontheplaceofcalciumantagonists |
_version_ |
1721270998109519872 |